Your browser doesn't support javascript.
loading
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort.
Waisman Malaret, Adrian J; Chang, Peter; Zhu, Kehao; Zheng, Yingye; Newcomb, Lisa F; Liu, Menghan; McKenney, Jesse K; Brooks, James D; Carroll, Peter; Dash, Atreya; Filson, Christopher P; Gleave, Martin E; Liss, Michael; Martin, Frances M; Morgan, Todd M; Nelson, Peter S; Lin, Daniel W; Wagner, Andrew A.
Afiliación
  • Waisman Malaret AJ; Department of Surgery, Division of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Chang P; Department of Surgery, Division of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Zhu K; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Zheng Y; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Newcomb LF; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Liu M; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • McKenney JK; Department of Pathology, Cleveland Clinic, Cleveland, Ohio.
  • Brooks JD; Department of Urology, Stanford University, Stanford, California.
  • Carroll P; Urology Department, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Dash A; Department of Urology, University of Washington, Seattle, Washington.
  • Filson CP; Department of Urology, Emory University, Atlanta, Georgia.
  • Gleave ME; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia.
  • Liss M; Department of Urology, University of Texas Health Sciences Center, San Antonio, Texas.
  • Martin FM; Urology of Virginia, Virginia Beach, Virginia.
  • Morgan TM; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Nelson PS; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Lin DW; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Wagner AA; Department of Urology, University of Washington, Seattle, Washington.
J Urol ; 207(4): 805-813, 2022 04.
Article en En | MEDLINE | ID: mdl-34854745
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Prostatectomía / Neoplasias de la Próstata / Espera Vigilante Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Urol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Prostatectomía / Neoplasias de la Próstata / Espera Vigilante Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Urol Año: 2022 Tipo del documento: Article